Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-25-089721

Options or other derivatives

  • Chief Commercial Officer acquired 185,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cline Darren S · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-23 Grant or award : show line 1 in the form Share Option (Right to Buy) +185,800 185,800 D
Loading xslF345X05/ownership.xml…